APD dialysis in small children with kidney failure
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how well and how safely a nightly dialysis machine (APD) works for young children with kidney failure. It aims to see if this treatment helps kids who are small (≤20 kg) stay healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have kidney failure and be on or starting automated peritoneal dialysis (APD).
- Your child must weigh 20 kg (about 44 pounds) or less.
- A legal guardian (like a parent) must sign a consent form. Your child also needs to agree to take part.
- Your child cannot have had peritonitis (belly infection) or an exit-site infection in the last 4 weeks.
- Your child must be expected to live more than 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares the effectiveness and resource use of remote patient monitoring across different dialysis methods for people with end-stage renal disease. It aims to see if remote monitoring can improve care and outcomes.
This study compares two forms of home peritoneal dialysis—how well they work for kidney health and how they affect daily life. You may be considered if you have end-stage kidney disease and meet specific test and safety requirements.
This trial tests if specially designed physical activity can help children and teens who are on hemodialysis for kidney failure. It aims to see if exercise improves their health and quality of life during treatment.
This study looks at improving how well dialysis removes waste from the blood and uses water in children. It may help make treatments more effective and efficient.
This study tests a special blood filtration machine (multiFiltratePRO) in children with kidney failure who need continuous dialysis. It aims to see how well the treatment works and if it's safe for younger patients.
This trial tests a modified version of daily peritoneal dialysis (M-CAPD) versus the standard version (C-CAPD) for children in low-resource settings who have end-stage kidney disease. It aims to see if the modified schedule works better for clearing waste and fluid.
Hear when a new Renal Failure Acute Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.